Home/Filings/4/0001209191-22-017119
4//SEC Filing

Favet Michael 4

Accession 0001209191-22-017119

CIK 0001528287other

Filed

Mar 7, 7:00 PM ET

Accepted

Mar 8, 4:43 PM ET

Size

7.4 KB

Accession

0001209191-22-017119

Insider Transaction Report

Form 4
Period: 2022-03-08
Favet Michael
DirectorChief Executive Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2022-03-08+310,160310,160 total
    Exercise: $8.10From: 2022-03-08Exp: 2032-03-07Common Stock (310,160 underlying)
  • Award

    Common Stock

    2022-03-08+155,080182,080 total
Footnotes (2)
  • [F1]Each share is represented by a restricted stock unit ("RSU"). Each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement. 25% of the RSUs vest on March 8, 2023 and the remaining RSUs vest in twelve (12) equal quarterly installments thereafter.
  • [F2]25% of the shares subject to the option vest on March 8, 2023. The remaining shares subject to the option vest in thirty six (36) equal consecutive monthly installments thereafter. The option is early exercisable.

Issuer

NeuroPace Inc

CIK 0001528287

Entity typeother

Related Parties

1
  • filerCIK 0001855656

Filing Metadata

Form type
4
Filed
Mar 7, 7:00 PM ET
Accepted
Mar 8, 4:43 PM ET
Size
7.4 KB